8FQ-40557-98965
3 vaccinations
4 coded responses
37 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 895 / NV
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-05
Registered in v-safe
-
2021-04-05
Dose 1 — Pfizer-BioNTech
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-19
-
2021-04-26
Dose 2 — Pfizer-BioNTech
- 2021-04-26
-
2021-04-27
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-28
- 2021-04-29
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-05-02
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-07
- 2021-07-26
-
2021-10-25
Survey response — 6 months, dose 2MedDRA: Arthralgia — Feeling: GoodFree text: Joint painMedDRA releases: 2024-11 · check-in free text available
-
2021-12-17
Dose 3 — Pfizer-BioNTech
-
2021-12-18
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-19
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-12-21
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
- 2021-12-22
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-01-14
-
2022-01-21
Survey response — day 35, dose 3MedDRA: Cough, Exposure to SARS-CoV-2, Fatigue, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend schoolFree text: General mild symptoms (congestion, sore throat, cough, fatigue) after being exposed to Covid- positive person in my house. I have had 3 negative at-home tests.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Survey response — day 42, dose 3MedDRA: Fatigue, Headache, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache, fatigue, runny nose, sneezing, congestion, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-03-18
Survey response — 3 months, dose 3MedDRA: COVID-19, Hypersensitivity, Seasonal allergy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Allergies/hayfever that I didn't previously have; unknown if it could be related to the vaccine or to Covid (positive in Jamuary), but it's significantly different now.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-17
- 2022-12-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | |
| 2 | 2021-04-26 | Pfizer-BioNTech | |
| 3 | 2021-12-17 | Pfizer-BioNTech | No |
Free text
Release 10 — 6 months, dose 2
Symptoms: Joint pain
Release 10 — day 35, dose 3
Symptoms: General mild symptoms (congestion, sore throat, cough, fatigue) after being exposed to Covid- positive person in my house. I have had 3 negative at-home tests.
Release 11 — day 42, dose 3
Symptoms: Headache, fatigue, runny nose, sneezing, congestion, sore throat
Release 11 — 3 months, dose 3
Symptoms: Allergies/hayfever that I didn't previously have; unknown if it could be related to the vaccine or to Covid (positive in Jamuary), but it's significantly different now.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Seasonal allergy | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release